rs35231465

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_002424.3(MMP8):​c.1348C>T​(p.Gln450*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0207 in 1,613,238 control chromosomes in the GnomAD database, including 442 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 38 hom., cov: 33)
Exomes 𝑓: 0.021 ( 404 hom. )

Consequence

MMP8
NM_002424.3 stop_gained

Scores

7

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.07

Publications

24 publications found
Variant links:
Genes affected
MMP8 (HGNC:7175): (matrix metallopeptidase 8) This gene encodes a member of the matrix metalloproteinase (MMP) family of proteins. These proteins are involved in the breakdown of extracellular matrix in embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Proteolysis at different sites on this protein results in multiple active forms of the enzyme with distinct N-termini. This protein functions in the degradation of type I, II and III collagens. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 11-102713404-G-A is Benign according to our data. Variant chr11-102713404-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 403101.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0154 (2340/152260) while in subpopulation NFE AF = 0.0244 (1662/68010). AF 95% confidence interval is 0.0235. There are 38 homozygotes in GnomAd4. There are 1075 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 38 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMP8NM_002424.3 linkc.1348C>T p.Gln450* stop_gained Exon 10 of 10 ENST00000236826.8 NP_002415.1 P22894

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMP8ENST00000236826.8 linkc.1348C>T p.Gln450* stop_gained Exon 10 of 10 1 NM_002424.3 ENSP00000236826.3 P22894
MMP8ENST00000528662.6 linkn.*1325C>T non_coding_transcript_exon_variant Exon 12 of 12 5 ENSP00000431431.2 E9PL87
MMP8ENST00000438475.2 linkc.*87C>T 3_prime_UTR_variant Exon 9 of 9 5 ENSP00000401004.2 H7C1M3
MMP8ENST00000528662.6 linkn.*1325C>T 3_prime_UTR_variant Exon 12 of 12 5 ENSP00000431431.2 E9PL87

Frequencies

GnomAD3 genomes
AF:
0.0154
AC:
2340
AN:
152142
Hom.:
38
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00490
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0146
Gnomad ASJ
AF:
0.0202
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0130
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0244
Gnomad OTH
AF:
0.0172
GnomAD2 exomes
AF:
0.0163
AC:
4086
AN:
250812
AF XY:
0.0165
show subpopulations
Gnomad AFR exome
AF:
0.00394
Gnomad AMR exome
AF:
0.0122
Gnomad ASJ exome
AF:
0.0196
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0163
Gnomad NFE exome
AF:
0.0256
Gnomad OTH exome
AF:
0.0200
GnomAD4 exome
AF:
0.0212
AC:
30974
AN:
1460978
Hom.:
404
Cov.:
31
AF XY:
0.0207
AC XY:
15051
AN XY:
726828
show subpopulations
African (AFR)
AF:
0.00275
AC:
92
AN:
33444
American (AMR)
AF:
0.0127
AC:
569
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.0199
AC:
519
AN:
26120
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39666
South Asian (SAS)
AF:
0.00129
AC:
111
AN:
86242
European-Finnish (FIN)
AF:
0.0174
AC:
927
AN:
53400
Middle Eastern (MID)
AF:
0.0102
AC:
59
AN:
5768
European-Non Finnish (NFE)
AF:
0.0248
AC:
27580
AN:
1111280
Other (OTH)
AF:
0.0185
AC:
1116
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
1428
2856
4284
5712
7140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
998
1996
2994
3992
4990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0154
AC:
2340
AN:
152260
Hom.:
38
Cov.:
33
AF XY:
0.0144
AC XY:
1075
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.00488
AC:
203
AN:
41564
American (AMR)
AF:
0.0146
AC:
223
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0202
AC:
70
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4822
European-Finnish (FIN)
AF:
0.0130
AC:
138
AN:
10614
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0244
AC:
1662
AN:
68010
Other (OTH)
AF:
0.0170
AC:
36
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
121
242
362
483
604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0220
Hom.:
150
Bravo
AF:
0.0156
TwinsUK
AF:
0.0259
AC:
96
ALSPAC
AF:
0.0304
AC:
117
ESP6500AA
AF:
0.00454
AC:
20
ESP6500EA
AF:
0.0226
AC:
194
ExAC
AF:
0.0161
AC:
1950
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.0251
EpiControl
AF:
0.0254

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 214/13004= 1.64% -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.32
CADD
Pathogenic
35
DANN
Benign
0.73
Eigen
Benign
-0.84
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.095
N
PhyloP100
2.1
Vest4
0.67
GERP RS
-2.5
Mutation Taster
=165/35
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35231465; hg19: chr11-102584135; COSMIC: COSV107247704; API